Collecting samples for lung disease and transplant research
Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant Research
This study is collecting samples from people with serious lung diseases and those who have had lung transplants to see if they can find clues that help diagnose and treat these conditions better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Baylor Research Institute Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT04664192 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect biological specimens from patients with advanced lung diseases and those who have undergone lung transplantation. The goal is to identify biomarkers that can help in the diagnosis, prognosis, and treatment of conditions such as interstitial lung disease and chronic obstructive pulmonary disease (COPD). By analyzing blood and tissue samples, researchers hope to enhance personalized medicine approaches and improve patient outcomes. The study will also explore the impact of genetic factors and infectious exposures on lung health.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and older who have undergone lung transplantation at Baylor University Medical Center within the last 10 years.
Not a fit: Patients with significant anemia, active cancer, or those unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and personalized treatment options for patients with advanced lung diseases.
How similar studies have performed: Other studies focusing on biomarker identification in lung diseases have shown promise, indicating that this approach is both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All individuals aged 18 years and older 2. Persons who have undergone lung transplantation at Baylor University Medical Center in the previous 10 years 3. Individual is able to understand and sign the informed consent form Exclusion Criteria: 1. Significant documented anemia (hemoglobin \<8 g/dL) 2. Blood transfusions within past 3 weeks 3. Active cancer (non-skin cancers) 4. Enrollment against doctor recommendation 5. Patient not able to provide informed consent
Where this trial is running
Dallas, Texas
- Baylor Scott & White Research Institute — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Susan Mathai, MD — Baylor Scott & White Research Institute
- Study coordinator: Susan Mathai, MD
- Email: Susan.Mathai@bswhealth.org
- Phone: 214-820-6856
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.